Alicia J. Hager

Directeur Juridique

Nkarta, Inc.OncoMed Pharmaceuticals Inc

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 1 saleFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (24 ops.)

€538k

Latest filing published 17 Jan 2025 for Nkarta, Inc., €20k.

Filing timeline

BuySale

Alicia J. Hager

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Alicia J. Hager: trading record in brief

Alicia J. Hager, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in OncoMed Pharmaceuticals Inc and Nkarta, Inc. In total, 41 filings cover trades dated from 25 March 2014 to 15 January 2025.

No open-market purchase appears, only 24 sales worth €538k. Besides market trades, the filings include 9 share grants and 7 option exercises. So far in 2025, the count stands at no purchases and 1 sale.

The latest filing, published on 17 January 2025, reports an open-market sale of €20k in Nkarta, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.